Gene · 7072
Papers4,191
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
801 to 820 of 4,191
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| T-Cell Non-Hodgkin Lymphoma of the Ileum Presenting as Perforation and Peritonitis: A Case Report. | Front Surg | 2022 | 35372472 | PubTator, text mining | PubMed |
| Emerging Roles for Phase Separation of RNA-Binding Proteins in Cellular Pathology of ALS. | Front Cell Dev Biol | 2022 | 35372329 | PubTator, text mining | PubMed |
| CD56-Negative Extranodal Natural Killer/T-Cell Lymphoma: A Retrospective Study in 443 Patients Treated by Chemotherapy With or Without Asparaginase. | Front Immunol | 2022 | 35371002 | PubTator, text mining | PubMed |
| A new strategy to count and sort neutrophil-derived extracellular vesicles: Validation in infectious disorders. | J Extracell Vesicles | 2022 | 35362257 | PubTator, text mining | PubMed |
| ENNGene: an Easy Neural Network model building tool for Genomics. | BMC Genomics | 2022 | 35361122 | PubTator, text mining | PubMed |
| [Clinicopathological features and prognosis of cytotoxic T-cell lymphoma: analysis of 134 cases]. | Zhonghua Bing Li Xue Za Zhi | 2022 | 35359038 | PubTator, text mining | PubMed |
| Neuropsychiatric Manifestations of Lymphoma-Associated Cerebral Glucose Hypometabolism Can Be Reversed by Intensive Glucose Supplementation. | Blood Lymphat Cancer | 2022 | 35356784 | PubTator, text mining | PubMed |
| First observation of intraocular extranodal natural killer/T-cell lymphoma secondary to a retroperitoneal tumour: a case report and comparative review. | BMC Ophthalmol | 2022 | 35346113 | PubTator, text mining | PubMed |
| Aggressive Natural Killer Cell Leukemia: A Brief Overview of Its Genomic Landscape, Histological Features, and Current Management. | Cureus | 2022 | 35345687 | PubTator, text mining | PubMed |
| A Tug of War: Pseudorabies Virus and Host Antiviral Innate Immunity. | Viruses | 2022 | 35336954 | PubTator, text mining | PubMed |
| Amyloid Cross-Seeding: Mechanism, Implication, and Inhibition. | Molecules | 2022 | 35335141 | PubTator, text mining | PubMed |
| Emerging insights into the complex genetics and pathophysiology of amyotrophic lateral sclerosis. | Lancet Neurol | 2022 | 35334234 | PubTator, text mining | PubMed |
| Recent advances in the diagnosis and prognosis of amyotrophic lateral sclerosis. | Lancet Neurol | 2022 | 35334233 | PubTator, text mining | PubMed |
| The Effect of the Tumor Microenvironment on Lymphoid Neoplasms Derived from B Cells. | Diagnostics (Basel) | 2022 | 35328127 | PubTator, text mining | PubMed |
| ADP-Ribosylation Post-Translational Modification: An Overview with a Focus on RNA Biology and New Pharmacological Perspectives. | Biomolecules | 2022 | 35327636 | PubTator, text mining | PubMed |
| Molecular Mechanisms of Anti-Neoplastic and Immune Stimulatory Properties of Oncolytic Newcastle Disease Virus. | Biomedicines | 2022 | 35327364 | PubTator, text mining | PubMed |
| Polymerase Epsilon-Associated Ultramutagenesis in Cancer. | Cancers (Basel) | 2022 | 35326618 | PubTator, text mining | PubMed |
| Temporal control of the integrated stress response by a stochastic molecular switch. | Sci Adv | 2022 | 35319985 | PubTator, text mining | PubMed |
| Medullary breast cancer is a predominantly triple-negative breast cancer - histopathological analysis and comparison with invasive ductal breast cancer. | Arch Med Sci | 2022 | 35316897 | PubTator, text mining | PubMed |
| Case Report: Primary Indolent Epstein-Barr Virus-Positive T-Cell Lymphoproliferative Disease Involving the Central Nervous System. | Front Surg | 2022 | 35310431 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/7072/papers?page=41